Matching-Adjusted Indirect Comparisons (MAICS) of Efficacy and Consumption of Bay 94-9027 Versus three Recombinant Factor VIII (RFVIII) for Prophylaxis of Severe Hemophilia A
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1670
https://www.valueinhealthjournal.com/article/S1098-3015(18)31992-2/fulltext
Title :
Matching-Adjusted Indirect Comparisons (MAICS) of Efficacy and Consumption of Bay 94-9027 Versus three Recombinant Factor VIII (RFVIII) for Prophylaxis of Severe Hemophilia A
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31992-2&doi=10.1016/j.jval.2018.04.1670
First page :
Section Title :
Open access? :
No
Section Order :
890